An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases

免疫系统 免疫学 细胞因子 医学 抗体 药理学 肿瘤坏死因子α 关节炎 炎症 单克隆抗体
作者
Michael J. McPherson,Adrian D. Hobson,Axel Hernandez,Christopher C. Marvin,Wendy Waegell,Christian Goess,Jason Z. Oh,Dan Shi,Martin E. Hayes,Limantian Wang,Lu Wang,Diana L. Schmidt,Zhi Wang,Victoria Pitney,Kimberley McCarthy,Ying Jia,Ce Wang,Bit Na Kang,Shaughn H. Bryant,Suzanne Mathieu
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science]
卷期号:16 (739): eadd8936-eadd8936 被引量:39
标识
DOI:10.1126/scitranslmed.add8936
摘要

Glucocorticoids (GCs) are efficacious drugs used for treating many inflammatory diseases, but the dose and duration of administration are limited because of severe side effects. We therefore sought to identify an approach to selectively target GCs to inflamed tissue. Previous work identified that anti-tumor necrosis factor (TNF) antibodies that bind to transmembrane TNF undergo internalization; therefore, an anti-TNF antibody-drug conjugate (ADC) would be mechanistically similar, where lysosomal catabolism could release a GC receptor modulator (GRM) payload to dampen immune cell activity. Consequently, we have generated an anti-TNF-GRM ADC with the aim of inhibiting pro-inflammatory cytokine production from stimulated human immune cells. In an acute mouse model of contact hypersensitivity, a murine surrogate anti-TNF-GRM ADC inhibited inflammatory responses with minimal effect on systemic GC biomarkers. In addition, in a mouse model of collagen-induced arthritis, single-dose administration of the ADC, delivered at disease onset, was able to completely inhibit arthritis for greater than 30 days, whereas an anti-TNF monoclonal antibody only partially inhibited disease. ADC treatment at the peak of disease was also able to attenuate the arthritic phenotype. Clinical data for a human anti-TNF-GRM ADC (ABBV-3373) from a single ascending dose phase 1 study in healthy volunteers demonstrated antibody-like pharmacokinetic profiles and a lack of impact on serum cortisol concentrations at predicted therapeutic doses. These data suggest that an anti-TNF-GRM ADC may provide improved efficacy beyond anti-TNF alone in immune mediated diseases while minimizing systemic side effects associated with standard GC treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被zhou采纳,获得10
刚刚
科研通AI6.3的应助被幸运鹅采纳,获得10
1秒前
于十Zzzz完成签到 ,获得积分10
1秒前
1秒前
1秒前
1秒前
小王小王发布了新的文献求助10
2秒前
2秒前
Harry发布了新的文献求助20
3秒前
田様的应助被冲冲采纳,获得10
5秒前
6秒前
www的应助被山海不远采纳,获得10
6秒前
7秒前
刘亦菲完成签到,获得积分10
7秒前
Little_可爱发布了新的文献求助10
8秒前
9秒前
科研通AI6.4的应助被zx采纳,获得10
9秒前
大太阳完成签到 ,获得积分10
9秒前
molihuakai的应助被6yy采纳,获得30
9秒前
丘比特的应助被Run采纳,获得10
9秒前
11秒前
Hello的应助被笙笙采纳,获得10
11秒前
蓝色雨完成签到,获得积分10
12秒前
12秒前
领导范儿的应助被心想事成采纳,获得10
13秒前
心房子完成签到,获得积分10
13秒前
13秒前
koukaki完成签到,获得积分10
14秒前
犹豫访天完成签到,获得积分10
14秒前
Little_可爱完成签到,获得积分10
14秒前
14秒前
Lemonhead的应助被HHHHHH采纳,获得30
15秒前
16秒前
AN发布了新的文献求助10
16秒前
OK发布了新的文献求助10
16秒前
17秒前
18秒前
万能图书馆的应助被三分之二采纳,获得10
19秒前
搜集达人的应助被Kevin采纳,获得10
19秒前
漏漏漏发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177767
求助须知:如何正确求助?哪些是违规求助? 9568590
关于积分的说明 21799821
捐赠科研通 7772374
什么是DOI,文献DOI怎么找? 3432476
关于科研通互助平台的介绍 2556695
邀请新用户注册赠送积分活动 2478034